brexucabtagene autoleucel
gilead sciences
['zuma-2', 'car t']
at #asco22, our experts are presenting promising new clinical data in blood cancers. see the highlights, which include three-year data from zuma-2, gamma delta car t cell therapy and nk cell combination treatment: #endcancer
Driven by our mission to #EndCancer, MD Anderson is a leader in cancer care, research, education and training, and prevention. Appointments: 1-877-632-6789